813 related articles for article (PubMed ID: 25682608)
1. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
[TBL] [Abstract][Full Text] [Related]
2. Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.
Lev PR; Grodzielski M; Goette NP; Glembotsky AC; Espasandin YR; Pierdominici MS; Contrufo G; Montero VS; Ferrari L; Molinas FC; Heller PG; Marta RF
Br J Haematol; 2014 Jun; 165(6):854-64. PubMed ID: 24673454
[TBL] [Abstract][Full Text] [Related]
3. Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.
Arnold DM; Nazi I; Toltl LJ; Ross C; Ivetic N; Smith JW; Liu Y; Kelton JG
Eur J Haematol; 2015 Dec; 95(6):532-7. PubMed ID: 25684257
[TBL] [Abstract][Full Text] [Related]
4. Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.
Zhou H; Hou Y; Liu X; Qiu J; Feng Q; Wang Y; Zhang X; Min Y; Shao L; Liu X; Li G; Li L; Yang L; Xu S; Ni H; Peng J; Hou M
Thromb Haemost; 2015 May; 113(5):1021-34. PubMed ID: 25566808
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
[TBL] [Abstract][Full Text] [Related]
6. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
[TBL] [Abstract][Full Text] [Related]
7. Intrinsically impaired platelet production in some patients with persistent or chronic immune thrombocytopenia.
Rivière É; Viallard JF; Guy A; Kilani B; Vieira-Dias J; Pons AC; Couffinhal T; Pellegrin JL; James C
Br J Haematol; 2015 Aug; 170(3):408-15. PubMed ID: 25873418
[TBL] [Abstract][Full Text] [Related]
8. Humanized VB22B minibody for human Mpl stimulates human megakaryopoiesis but does not enhance platelet aggregation.
Matsuki E; Miyakawa Y; Yamane A; Okamoto S
Exp Hematol; 2011 Aug; 39(8):829-36. PubMed ID: 21605620
[TBL] [Abstract][Full Text] [Related]
9. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP.
McMillan R; Wang L; Tomer A; Nichol J; Pistillo J
Blood; 2004 Feb; 103(4):1364-9. PubMed ID: 14576051
[TBL] [Abstract][Full Text] [Related]
10. Quinine-induced thrombocytopenia: drug-dependent GPIb/IX antibodies inhibit megakaryocyte and proplatelet production in vitro.
Perdomo J; Yan F; Ahmadi Z; Jiang XM; Stocker R; Chong BH
Blood; 2011 Jun; 117(22):5975-86. PubMed ID: 21487107
[TBL] [Abstract][Full Text] [Related]
11. Influence of monoclonal antiplatelet glycoprotein antibodies on in vitro human megakaryocyte colony formation and proplatelet formation.
Takahashi R; Sekine N; Nakatake T
Blood; 1999 Mar; 93(6):1951-8. PubMed ID: 10068668
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia.
Guo L; Kapur R; Aslam R; Hunt K; Hou Y; Zufferey A; Speck ER; Rondina MT; Lazarus AH; Ni H; Semple JW
Scand J Immunol; 2018 Jul; 88(1):e12678. PubMed ID: 29855061
[TBL] [Abstract][Full Text] [Related]
13. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Gernsheimer TB
Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
[TBL] [Abstract][Full Text] [Related]
14. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
[TBL] [Abstract][Full Text] [Related]
15. Actin inhibition increases megakaryocyte proplatelet formation through an apoptosis-dependent mechanism.
Avanzi MP; Izak M; Oluwadara OE; Mitchell WB
PLoS One; 2015; 10(4):e0125057. PubMed ID: 25875470
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and pathophysiology of immune thrombocytopenic purpura.
Gernsheimer T
Eur J Haematol Suppl; 2008 Feb; (69):3-8. PubMed ID: 18211567
[TBL] [Abstract][Full Text] [Related]
17. A megakaryocyte with no platelets: anti-platelet antibodies, apoptosis, and platelet production.
Perdomo J; Yan F; Chong BH
Platelets; 2013; 24(2):98-106. PubMed ID: 22742725
[TBL] [Abstract][Full Text] [Related]
18. High doses of romiplostim induce proliferation and reduce proplatelet formation by human megakaryocytes.
Currao M; Balduini CL; Balduini A
PLoS One; 2013; 8(1):e54723. PubMed ID: 23359807
[TBL] [Abstract][Full Text] [Related]
19. Milestones in understanding platelet production: a historical overview.
Kuter DJ
Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody against integrin α
Zeng DF; Chen F; Wang S; Chen SL; Xu Y; Shen MQ; Du CH; Wang C; Kong PY; Cheng TM; Su YP; Wang JP
J Thromb Haemost; 2018 Sep; 16(9):1843-1856. PubMed ID: 29953749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
